Join Now Why Join?
Log In or Login with Facebook
Symbol Search  
or enter GC* - Gold Futures
Quotes and Charts
YOU ARE HERE:  Stocks » Quotes and Charts » News Headlines
+ Alert
+ Portfolio

Warner Chilcott Plc (WCRX)

20.61+1.01 (+5.15%) 7:50P EDT (NASDAQ)
Price Quote as of Wednesday, May 22nd, 2013

Latest Warner Chilcott Plc (WCRX) Headlines

Actavis to Buy Warner Chilcott - Analyst Blog

Zacks Equity Research - Zacks Investment Research - Tue May 21, 9:30PM CDT
The acquisition is expected to be accretive to Actavis' 2014 earnings per share by more than 30%. (full story)

Warner Chilcott Has Returned 52.4% Since SmarTrend Recommendation (WCRX)

Comtex SmarTrend(R) - Tue May 21, 5:14PM CDT
SmarTrend identified an Uptrend for Warner Chilcott (NASDAQ:WCRX) on January 17th, 2013 at $13.53. In approximately 4 months, Warner Chilcott has returned 52.38% as of today's recent price of $20.61. (full story)

Watch for Warner Chilcott to Potentially Pullback After Gaining 5.15% Yesterday

Comtex SmarTrend(R) - Tue May 21, 3:50PM CDT
Warner Chilcott (NASDAQ:WCRX) traded in a range yesterday that spanned from a low of $19.63 to a high of $20.64. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $20.30 on volume of 24.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Warner Chilcott Rises 5.15% on Heavy Volume: Watch For Potential Pullback

Comtex SmarTrend(R) - Tue May 21, 3:50PM CDT
Warner Chilcott (NASDAQ:WCRX) traded in a range yesterday that spanned from a low of $19.63 to a high of $20.64. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $20.30 on volume of 24.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

BBRY, YHOO and JASO added to Active Stock Watch List at GSR

ACCESSWIRE - Tue May 21, 8:33AM CDT
New York, NY -- (ACCESSWIRE -- 05/21/2013 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding Yahoo! Inc. (NASDAQ:YHOO), Research In Motion Limited (NASDAQ:BBRY), JA Solar Holdings Co., Ltd. (NASDAQ:JASO) and Warner Chilcott plc (NASDAQ:WCRX). (full story)

Earning Forecast Buzz for Warner Chilcott, Freeport-McMoRan Copper & Gold, Intel, EMC, Corning, and Barrick Gold

PR Newswire - Tue May 21, 8:00AM CDT
EarningForecast.com has issued earnings forecast reports for investors in US market: Warner Chilcott (NASDAQ:WCRX), Freeport-McMoRan Copper & Gold (NYSE:FCX), Intel (NASDAQ:INTC), EMC (NYSE:EMC), Corning (NYSE:GLW), and Barrick Gold (NYSE:ABX). (full story)

Downgrade Alert for Warner Chilcott (WCRX)

Comtex SmarTrend(R) - Tue May 21, 7:52AM CDT
Warner Chilcott (NASDAQ:WCRX) was downgraded from Positive to Neutral at Susquehanna today. The stock closed yesterday at $19.60 on volume of 59.8 million shares, above average daily volume of 6.0 million. Warner Chilcott Limited is a pharmaceutical company. The Company is focused on marketing, selling, developing and manufacturing branded prescription pharmaceutical products in women's healthcare and dermatology in the United States. (full story)

Downgrade Alert for Warner Chilcott (WCRX)

Comtex SmarTrend(R) - Tue May 21, 6:52AM CDT
Warner Chilcott (NASDAQ:WCRX) was downgraded from Buy to Hold at Needham today. The stock closed yesterday at $19.60 on volume of 59.8 million shares, above average daily volume of 6.0 million. There is potential upside of 5.2% for shares of Warner Chilcott based on a current price of $19.60 and an average consensus analyst price target of $20.62. The stock should discover initial support at its 50-day moving average (MA) of $14.57 and subsequent support at its 200-day MA of $13.66. (full story)

Market Maker Surveillance Report. GE, WCRX, RAD, FCX, FMCC, FNMA, Highest Net Buy Volume With Lowest Price Friction For Monday, May 20th 2013

M2 - Tue May 21, 3:00AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3903 companies with "abnormal" market making, 2886 companies with positive Friction Factors and 2231 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Monday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. General Electric Co (NYSE:GE), Warner Chilcott PLC (NASDAQ:WCRX), Rite Aid Corp (NYSE:RAD), Freeport-McMoRan Copper & Gold Inc (NYSE:FCX), Federal Home Loan Mortgage Corp (OTC:FMCC), Federal National Mortgage Association (OTC:FNMA). To access Friction Factor, Naked Short Data a (full story)

Actavis buying Warner Chilcott in $8.5B deal

By MICHELLE CHAPMAN and TOM MURPHY - AP - Mon May 20, 5:36PM CDT
NEW YORK (AP) — Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market. (full story)

Red Hat, JA Solar, Xenoport are big movers

AP - Mon May 20, 4:06PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: (full story)

News Summary: Actavis plans Warner Chilcott deal

By The Associated Press - AP - Mon May 20, 12:41PM CDT
THE OFFER: Actavis Inc. said Monday that it has agreed to buy fellow drugmaker Warner Chilcott PLC in an all-stock deal valued at about $8.5 billion. (full story)

Warner Chilcott Earnings In Retrospect: Up 6.7% in the Last 10 Days (WCRX)

Comtex SmarTrend(R) - Mon May 20, 12:12PM CDT
A week ago on May 10th, 2013 Warner Chilcott (NASDAQ:WCRX) reported earnings and analysts, on average, expected earnings of $0.85 on sales of $592.1 million. Warner Chilcott actually reported earnings of $0.92 per share on sales of $593.0 million, beating EPS estimates by $0.07 and beating revenue estimates by $0.9 million. Shares of Warner Chilcott have climbed from $18.01 to $19.21, representing a gain of 6.7% since the company reported earnings 10 days ago. (full story)

Fitch: Warner Chilcott Deal In Line with Actavis' 'BBB-' Ratings

Business Wire - Mon May 20, 10:47AM CDT
The proposed $8.5 billion all-stock merger between Warner Chilcott plc and Actavis, Inc. is in line with Actavis' current 'BBB-' ratings, according to Fitch Ratings. A complete list of Actavis' ratings follows at the end of this release. (full story)

Announcement Under Irish Takeover Rules Revision to Relevant Securities in Issue

GlobeNewswire - Mon May 20, 8:00AM CDT
In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "Company") confirms that, as of the close of business on May 15, 2013, the Company's issued share capital consisted of 250,922,431 ordinary shares, par value US$0.01 per share (the "Ordinary Shares"). The CUSIP number for the Ordinary Shares is G94368100. (full story)

Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company

PR Newswire Europe - Mon May 20, 6:28AM CDT
- Top 3 U.S. ~$3.0 Billion Revenue Specialty Brand Business - (full story)

Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company

PR Newswire - Mon May 20, 6:06AM CDT
Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced they have entered into a definitive agreement under which Actavis will acquire Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion. If successfully completed, the transaction will create a leading global specialty pharmaceutical company with approximately $11 billion in combined annual revenue, and the third-largest U.S. specialty pharmaceutical company with approximately $3 billion in annual revenues focused on core therapeutic categories of Women's Health, Gastroenterology, Urology and Dermatology. The proposed transaction has been unanimously approved by the Boards of Directors of Actavis, Inc. and Warner Chilcott plc, and is supported by the management teams of both companies. (full story)

Drugmaker Actavis' shares up

By The Associated Press - AP - Thu May 16, 8:39AM CDT
Shares of Actavis Inc. rose Thursday after reports surfaced that one of the world's biggest generic drugmaker has drawn interest from some competitors considering an acquisition. (full story)

StockCall Early Morning Insight into WCRX, DVAX, ISIS, ACT, and AVNR

ACCESSWIRE-TNW - Wed May 15, 7:01AM CDT
StockCall.com Provides Stock Research on Warner Chilcott plc, Dynavax Technologies Corp., Isis Pharmaceuticals Inc., Actavis Inc., and Avanir Pharmaceuticals. (full story)

Fitch: Strategic Actavis/Warner Combo Could Pressure Credit

Business Wire - Tue May 14, 12:16PM CDT
A combination of generic drug maker Actavis and specialty pharmaceutical company Warner Chilcott makes strategic sense but could pressure credit, according to Fitch Ratings. Actavis (formerly known as Watson Pharmaceuticals) Friday confirmed it had entered into early stage discussions with Warner Chilcott regarding a potential combination. (full story)
*Older Stories